NCT00012337View on ClinicalTrials.gov

ZD 1839 in Treating Patients With Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2001

Study Completion Date

March 31, 2004

Conditions
Kidney Cancer
Interventions
DRUG

gefitinib

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00012337 - ZD 1839 in Treating Patients With Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter